Gregory H. Tesch

Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity.

Y. S. Kim, T. Strom, W. Maśliński, 1998, Journal of immunology.